IP Library Granted Patent US 12,440,680
Granted Patent B2
US 12,440,680 · App. 17/692,807 · Granted Oct 14, 2025

Methods of treating disease by skewing macrophage phenotype with alternating electric fields

Inventors: Tali Voloshin-Sela (Kibbutz Gvat, IL); Lilach Avigdor (Haifa, IL); Boris Brant (Haifa, IL)
Assignee: Novocure GmbH
A61N1/36171A61K45/06A61N1/36007A61N1/3601
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,440,680
App. No.
17/692,807
Granted
Oct 14, 2025
Kind
B2
Abstract

Methods of treating diseases and infections by applying alternating electric fields to tissues followed by administering a treatment for the disease or infection are provided. In some instances, alternating electric fields can be applied at least until substantial improvement in disease manifestation. The exemplary methods can be used to treat kidney, heart, brain, and bone disease and conditions.

Claims (8)

1. A method of treating an infection in a subject, comprising:

applying alternating electric fields of frequency between 50 and 500 kHz and field strength of 0.1 to 10 V/cm to the subject; and

administering a therapeutically effective amount of an antibiotic for treating the infection to the subject; wherein the infection is with:

Tropheryma whipplei , or Salmonella in a digestive system and the alternating electric fields are applied to the digestive system of the subject.

2. The method of claim 1 , wherein the infection is with Tropheryma whipplei , or Salmonella in a digestive system of the subject, and wherein the antibiotic is selected from the group consisting of one or more of penicillin, streptomycin, tetracycline, ceftriaxone, meropenem, co-trimoxazole, doxycycline, hydroxychloroquine, fluoroquinolones, and azithromycin.

3. The method of claim 2 , wherein the frequency is between 125 and 175 kHz.

4. The method of claim 2 , wherein the alternating electric fields are applied for at least 24 hours.

5. The method of claim 2 , wherein the alternating electric fields are applied until the digestive system of the subject is not infected with Tropheryma whipplei , or Salmonella.

Assignments (2)
PATENT SECURITY AGREEMENT Recorded May 4, 2024
From: NOVOCURE GMBH (SWITZERLAND)
To: BIOPHARMA CREDIT PLC
Reel/Frame 067315/0399 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 9, 2022
From: AVIGDOR, LILACH; VOLOSHIN-SELA, TALI; BRANT, BORIS
To: NOVOCURE GMBH
Reel/Frame 059871/0019 →